Transient versus Persistent BK Viremia and Long-Term Outcomes after Kidney and Kidney-Pancreas Transplantation

被引:70
作者
Elfadawy, Nissreen [1 ]
Flechner, Stuart M. [1 ]
Schold, Jesse D. [2 ]
Srinivas, Titte R. [4 ]
Poggio, Emilio [1 ]
Fatica, Richard [1 ]
Avery, Robin [5 ]
Mossad, Sherif B. [3 ]
机构
[1] Cleveland Clin, Glickman Urol & Kidney Inst, Cleveland, OH 44106 USA
[2] Cleveland Clin, Dept Quantitat Hlth Sci, Cleveland, OH 44106 USA
[3] Cleveland Clin, Dept Infect Dis, Inst Med, Cleveland, OH 44106 USA
[4] Med Univ S Carolina, Div Nephrol, Charleston, SC 29425 USA
[5] Johns Hopkins Univ, Div Infect Dis, Baltimore, MD USA
来源
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2014年 / 9卷 / 03期
关键词
POLYOMAVIRUS-ASSOCIATED NEPHROPATHY; RENAL-TRANSPLANTATION; VIRUS NEPHRITIS; VIRAL LOAD; RECIPIENTS; INFECTION; ALLOGRAFT; REPLICATION; PCR;
D O I
10.2215/CJN.08420813
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background and objectives The objective was to study the long-term impact of transient versus persistent BK viremia on kidney transplant outcomes. Design, setting, participants, & measurements In total, 609 recipients who underwent kidney transplant from 2007 to 2011 were screened at months 1-12 for the occurrence of polyomavirus BK viremia; 130 patients (21.7%) developed BK viremia during the first year post-transplant. BK viremia patients were classified according to duration of infection (more or less than 3 months), and BK viral loads (more or less than 10,000 copies/ml) were classified as transient low viremia (n=42), transient high viremia (n=18), persistent low viremia (n=23), and persistent high viremia (n=47). All patients were followed a median of 36 (3-66) months. The rates of BK polyomavirus-associated nephropathy, acute rejection, and 1-year graft function were compared with the polyomavirus BK-negative control group. Results Patient and graft survival were not significantly different among the groups. Graft function (creatinine; milligrams per deciliter) at 1 year was significantly worse in the persistent high viremia (1.75 +/- 0.6) and transient high viremia (1.85 +/- 0.7) groups compared with aviremic controls (1.47 +/- 0.4; P=0.01 and P=0.01, respectively). The incidence of BK polyomavirus-associated nephropathy was limited to the persistent high viremia group (1.3%, P<0.001). The transient high viremia (50%) and persistent high viremia (34%) groups showed significantly (P=0.01) increased incidence of acute rejection versus aviremic controls (21.5%), transient low viremia (19%), or persistent low viremia (17.3%) groups. Conclusion Low viral load BK viremia, either transient or persistent, was not associated with long-term transplant outcomes. Persistent high viremia was associated with a greater risk for BK polyomavirus-associated nephropathy and subsequent graft dysfunction. Although transient high viremia was not associated with BK polyomavirus-associated nephropathy, it was associated with worse graft function. These data support the role of surveillance for BK viremia after transplant.
引用
收藏
页码:553 / 561
页数:9
相关论文
共 25 条
[1]   Polyoma virus infection after renal transplantation - Use of immunostaining as a guide to diagnosis [J].
Ahuja, M ;
Cohen, EP ;
Dayer, AM ;
Kampalath, B ;
Chang, CC ;
Bresnahan, BA ;
Hariharan, S .
TRANSPLANTATION, 2001, 71 (07) :896-899
[2]   Sustained BK Viruria as an Early Marker for the Development of BKV-Associated Nephropathy: Analysis of 4128 Urine and Serum Samples [J].
Babel, Nina ;
Fendt, Juliane ;
Karaivanov, Stoyan ;
Bold, Gantuja ;
Arnold, Steffen ;
Sefrin, Anett ;
Lieske, Evelyn ;
Hoffzimmer, Martin ;
Dziubianau, Mikalai ;
Bethke, Nicole ;
Meisel, Christian ;
Gruetz, Gerald ;
Reinke, Petra .
TRANSPLANTATION, 2009, 88 (01) :89-95
[3]   BK Virus-Specific T Cells for Use in Cellular Therapy Show Specificity to Multiple Antigens and Polyfunctional Cytokine Responses [J].
Blyth, Emily ;
Clancy, Leighton ;
Simms, Renee ;
Gaundar, Shivashni ;
O'Connell, Philip ;
Micklethwaite, Kenneth ;
Gottlieb, David J. .
TRANSPLANTATION, 2011, 92 (10) :1077-1084
[4]   Donor origin of BK virus in renal transplantation and role of HLA C7 in susceptibility to sustained BK viremia [J].
Bohl, DL ;
Storch, GA ;
Ryschkewitsch, C ;
Gaudreault-Keener, M ;
Schnitzler, MA ;
Major, EO ;
Brennan, DC .
AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 (09) :2213-2221
[5]   Clinical usefulness of BK virus plasma quantitative PCR to prevent BK virus associated nephropathy [J].
Chung, Byung Ha ;
Hong, Yu Ah ;
Kim, Hyun Gyung ;
Sun, In O. ;
Choi, Sun Ryoung ;
Park, Hoon Suk ;
Lee, Sung Hak ;
Choi, Bum Soon ;
Park, Cheol Whee ;
Choi, Yeong Jin ;
Kim, Yong-Soo ;
Yang, Chul Woo .
TRANSPLANT INTERNATIONAL, 2012, 25 (06) :687-695
[6]   Histological patterns of polyomavirus nephropathy: Correlation with graft outcome and viral load [J].
Drachenberg, CB ;
Papadimitriou, JC ;
Hirsch, HH ;
Wali, R ;
Crowder, C ;
Nogueira, J ;
Cangro, CB ;
Mendley, S ;
Mian, A ;
Ramos, E .
AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (12) :2082-2092
[7]  
Elfadawy N, TRANSPLANTATION
[8]   BK-Virus and the Impact of Pre-Emptive Immunosuppression Reduction: 5-Year Results [J].
Hardinger, K. L. ;
Koch, M. J. ;
Bohl, D. J. ;
Storch, G. A. ;
Brennan, D. C. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 (02) :407-415
[9]   Research electronic data capture (REDCap)-A metadata-driven methodology and workflow process for providing translational research informatics support [J].
Harris, Paul A. ;
Taylor, Robert ;
Thielke, Robert ;
Payne, Jonathon ;
Gonzalez, Nathaniel ;
Conde, Jose G. .
JOURNAL OF BIOMEDICAL INFORMATICS, 2009, 42 (02) :377-381
[10]   Polyomavirus BK Replication in De Novo Kidney Transplant Patients Receiving Tacrolimus or Cyclosporine: A Prospective, Randomized, Multicenter Study [J].
Hirsch, H. H. ;
Vincenti, F. ;
Friman, S. ;
Tuncer, M. ;
Citterio, F. ;
Wiecek, A. ;
Scheuermann, E. H. ;
Klinger, M. ;
Russ, G. ;
Pescovitz, M. D. ;
Prestele, H. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 (01) :136-145